AGP Picks
View all

Health Update Bahamas
Provided by AGP

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

July 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

Press releases published on July 22, 2026

Traferox Technologies Receives FDA Premarket Approval for the TorEx Lung Perfusion System
18 hours ago

Traferox Technologies Receives FDA Premarket Approval for the TorEx Lung Perfusion System

Indeterminate GlobeNewswire
Specialized Manufacturing Capability Emerges as the New Competitive Advantage in the $23.2 Billion Global Biologics CDMO Market, Finds Alira Health
18 hours ago

Specialized Manufacturing Capability Emerges as the New Competitive Advantage in the $23.2 Billion Global Biologics CDMO Market, Finds Alira Health

Indeterminate GlobeNewswire
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity
18 hours ago

Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity

Indeterminate GlobeNewswire
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition
18 hours ago

New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition

Indeterminate GlobeNewswire
New CMS Results Validate Empassion's Unique Approach to Serious Illness Care
Jul. 22, 2026

New CMS Results Validate Empassion's Unique Approach to Serious Illness Care

Indeterminate GlobeNewswire
Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer
Jul. 22, 2026

Exubrion Therapeutics Promotes Gregory Taglialatela to Chief Commercial Officer

Indeterminate GlobeNewswire
Med X Holdings Announces Official Name Change to Dazed Inc. and New Ticker Symbol "DAZD"
Jul. 22, 2026

Med X Holdings Announces Official Name Change to Dazed Inc. and New Ticker Symbol "DAZD"

Indeterminate GlobeNewswire
Bluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital Pharmacies
Jul. 22, 2026

Bluesight and Pfizer Partner to Provide Source-Tagged RFID Medications to Hospital Pharmacies

Indeterminate GlobeNewswire
Veraify Launches Groundbreaking AI-Native Security Platform Built for the AI Workforce Era
Jul. 22, 2026

Veraify Launches Groundbreaking AI-Native Security Platform Built for the AI Workforce Era

Indeterminate GlobeNewswire
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
Jul. 22, 2026

Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026

Indeterminate GlobeNewswire
Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
Jul. 22, 2026

Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease

Indeterminate GlobeNewswire
VisiRose Selected to Present RB-PDAT at ESCRS iNovation® Day 2026 Emerging Company Showcase
Jul. 22, 2026

VisiRose Selected to Present RB-PDAT at ESCRS iNovation® Day 2026 Emerging Company Showcase

Indeterminate GlobeNewswire
KC BioHub Awarded $38.1 Million to Advance Regional Biomanufacturing Growth
Jul. 22, 2026

KC BioHub Awarded $38.1 Million to Advance Regional Biomanufacturing Growth

Indeterminate GlobeNewswire
Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors 
Jul. 22, 2026

Inspire Medical Systems, Inc. Announces Retirement of Casey M. Tansey from its Board of Directors 

Indeterminate GlobeNewswire
LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia
Jul. 22, 2026

LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia

Indeterminate GlobeNewswire
Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial Officer
Jul. 22, 2026

Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial Officer

Indeterminate GlobeNewswire
Canadian Pet Parents Continue to Prioritize Pet Spending over their Everyday Pleasures
Jul. 22, 2026

Canadian Pet Parents Continue to Prioritize Pet Spending over their Everyday Pleasures

Indeterminate GlobeNewswire
Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call
Jul. 22, 2026

Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call

Indeterminate GlobeNewswire
BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1
Jul. 22, 2026

BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1

Indeterminate GlobeNewswire
Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
Jul. 22, 2026

Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health Update Bahamas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.